FDA to Review Spectrum Pharma Beleodaq – Zacks.com
FDA to Review Spectrum Pharma BeleodaqZacks.comThe candidate is being developed as a conditioning agent for stem cell transplant and multiple myeloma. The company expects to report top-line data from a pivotal study on captisol-enabled melphalan in the…